Latest Deals
CMR Surgical is anticipating the broadening its clinical footprint through two ongoing trials. Credit: T Schneider / Shutterstock
CMR secures over $200m to commercialise surgical robotic system
CMR Surgical has completed a financing round of more than $200m to expedite the commercialisation of its Versius Surgical Robotic System, particularly focusing on the US market. Through these funds, the company also aims to bolster its growth strategy. The financing round is supported by all current investors and includes a debt investment from alternative asset manager Trinity Capital, which has pledged up to $68.75m in growth capital to the company.
Brainomix concludes $18m fund raise to strengthen US presence
UK-based Brainomix has completed a £14m ($18m) Series C funding round to advance commercial expansion in the US. A spinout of Oxford University, the company’s suite of artificial intelligence (AI)-based imaging tools for stroke and fibrosis management are deployed via the Brainomix Stroke 360 platform.
Proscia scoops $50m for AI-driven pathology advancement
AUS-based pathology software provider has completed a $50m fund raise to advance its artificial intelligence (AI)-driven digital pathology platform. Currently used by 16 of the 20 leading players in the pharmaceuticals space, Proscia’s Concentriq platform is comprised of three solutions designed to advance image-based scientific workflows and pathology labs’ digitisation efforts.
Cardiac Dimensions snags $53m for mitral valve device
Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment management firm Ally Bridge Group, with participation from new investor Claret Capital Partners and existing investors Hostplus, M.H. Carnegie, Horizon 3 Healthcare, and Lumira Ventures.
